{"schema_version":"secwatch.filing_event.v1","accession":"0001601485-23-000062","form_type":"8-K","ticker":"ELTX","cik":"0001601485","company_name":"Elicio Therapeutics, Inc.","filed_at":"2023-10-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.719860+00:00","generated_at":"2026-06-10T00:43:13.096028+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"medium","headline":"Elicio Therapeutics terminates Chief Business Officer Annette Matthies without cause","bullets":["Annette Matthies, Ph.D., Chief Business Officer, terminated without cause effective October 5, 2023.","No replacement or interim successor named in the filing.","Separation is effective as of the date of termination."],"urls":{"canonical":"https://secwatch.observer/filing/0001601485-23-000062","json":"https://secwatch.observer/filing/0001601485-23-000062.json","markdown":"https://secwatch.observer/filing/0001601485-23-000062.md","text":"https://secwatch.observer/filing/0001601485-23-000062.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1601485/000160148523000062/0001601485-23-000062-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1601485/000160148523000062/angn-20231005.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T00:43:13.096028+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"92336313f8","claim":"Annette Matthies departed as Chief Business Officer at Elicio Therapeutics, Inc..","evidence_excerpt":"On October 5, 2023, Annette Matthies, Ph.D., Chief Business Officer of Elicio Therapeutics, Inc. (the “Company”) was terminated without cause, effective as of the same date (the “Separation Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148523000062/0001601485-23-000062-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated without cause"},{"label":"Role","value":"Chief Business Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}